Global Kinetics Pty Ltd. is committed to improving the lives of those with Parkinson's disease with advanced medical technologies. The company was formed in order to commercialise its lead product, the Personal KinetiGraph™ (PKG™), also known as the Parkinson's KinetiGraph™ outside the USA. Developed in conjunction with the world-renowned Florey Institute of Neuroscience & Mental Health in Melbourne, Australia, the PKG enables the precise monitoring, quantification, and reporting of movement symptoms in Parkinson's. To date, Global Kinetics has supported clinical decisions for doctors who treat patients with Parkinson's disease across 17 countries with more than 3,000,000 hours of clinical data from our FDA-cleared, CE-marked PKG wearable device. Global Kinetics, a privately held company, is headquartered in Melbourne, Australia with offices in London, UK, Minneapolis, MN, and Portsmouth, NH, USA.